Legasbi, Vina T.

HRN: 27-45-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
METRONIDAZOLE 500MG (TAB)
07/15/2025
07/23/2025
ORAL
500mg
Q8
Amoeba
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines